Psychedelic-assisted therapy for substance use disorders: Between urgency and uncertainty.
Am J Addict March 1, 2026
Psychedelic-assisted therapy for substance use disorders: Between urgency and uncertainty.
Am J Addict
ISSN 1055-0496; 1521-0391;
2 papers in the library · 17 citations · publishing 2015-2026
Papers
Intensive ketamine use for multiple years: A case report.
Am J Addict 2015 James X. Liu, Erin Zerbo, Stephen Ross 17 citations
Ketamine is known within the medical field for its anesthetic properties, yet its unique psychedelic and antidepressant properties are being increasingly recognized. We document the case of a patient with bipolar I disorder and an extensive history of substance dependence who used large doses of ketamine (1-3 g) on a daily basis over a period of 5 years, and described acute antidepressant...